clenoliximab
mAbexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- T-cell surface antigen CD4INHIBITOR
CD4 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108187 ↗
Also known as
- ce9?4pe
- clenoliximab
- clenoliximab
- idec-151
- idec-151
- sb-217969